Is It Time to Move Beyond Graft-Versus-Host Disease-Free, Relapse-Free Survival as a Primary End Point in Clinical Trials for Hematopoietic Cell Transplantation?
A
Amar H. Kelkar
(Department of Medical Oncology, Dana–Farber Cancer Institute, Boston)
G
Gregory A. Abel
(Dana-Farber Cancer Institute, Boston, Massachusetts, United States)
C
Corey S. Cutler
(7Division of Hematologic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA)
S
Stephanie J. Lee
R
Robert J. Soiffer
(Dana-Farber Cancer Institute)
Article Details
Journal
Journal of Clinical Oncology
Volume / Issue
Vol. 44, Issue 15
Published
May 20, 2026
Pages
1389-1394
ISSN
0732-183X
Publisher
Lippincott Williams & Wilkins
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences
Authors (5)
A
Amar H. Kelkar
Department of Medical Oncology, Dana–Farber Cancer Institute, Boston
G
Gregory A. Abel
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
C
Corey S. Cutler
7Division of Hematologic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
S
Stephanie J. Lee
R
Robert J. Soiffer
Dana-Farber Cancer Institute
Related Articles from this Journal
Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer
Ismaela Anna Vascotto, Filippo Antonica et al.
Aug 2026
10.1200/jco-26-00658
Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial
Samer A. Srour, Jad Chahoud et al.
Aug 2026
10.1200/jco-26-00388
Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection
Risako Komata, Kenju Ando et al.
Aug 2026
10.1200/jco-26-00140
Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)
Ghayas C. Issa, Branko Cuglievan et al.
Aug 2026
10.1200/jco-26-01743
Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer
Irbaz Bin Riaz, R. Bryan Rumble et al.
Aug 2026
10.1200/jco-26-01001